Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus and Cyclophosphamide in Metastatic Renal Cell Cancer
NCT01462214Phase 2Completed
- Start
- Oct 2011
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide in metastatic renal cell carcinoma (mRCC). Started Oct 2011; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on NCT01462214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01462214.